Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J O Hambro Capital Management (JOHCM) is an active investment management firm headquartered in London, United Kingdom. Established in 1996, the company specializes in managing high-conviction equity portfolios for institutional and professional investors globally. While not a biotechnology or pharmaceutical developer itself, JOHCM is a significant institutional investor in the life sciences sector, managing funds that hold substantial positions in global healthcare, biotech, and medical technology companies. The firm operates as a boutique investment house under its parent company, Perpetual Limited, following a series of corporate acquisitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J O Hambro Capital Management Group.